Renaissance Technologies - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q2 2024$500,688
+81312.7%
215,814
-1.0%
0.00%0.0%
Q1 2024$615
-12.8%
218,014
-1.6%
0.00%0.0%
Q4 2023$705
-5.7%
221,614
-2.2%
0.00%0.0%
Q3 2023$748
-2.0%
226,714
-1.9%
0.00%0.0%
Q2 2023$763
+0.3%
231,159
+0.5%
0.00%0.0%
Q1 2023$761
-9.6%
229,914
-1.4%
0.00%0.0%
Q4 2022$842
-100.0%
233,114
-6.9%
0.00%
-66.7%
Q3 2022$2,217,000
+6.6%
250,513
-7.3%
0.00%
+50.0%
Q2 2022$2,080,000
-18.6%
270,112
-0.6%
0.00%
-33.3%
Q1 2022$2,554,000
+33.0%
271,712
-1.9%
0.00%
+50.0%
Q4 2021$1,920,000
-29.5%
277,112
-3.2%
0.00%
-50.0%
Q3 2021$2,724,000
-10.9%
286,412
-6.3%
0.00%0.0%
Q2 2021$3,058,000
-21.4%
305,757
-8.0%
0.00%
-20.0%
Q1 2021$3,889,000
-64.7%
332,419
+7.6%
0.01%
-58.3%
Q4 2020$11,028,000
+160.7%
308,812
+0.9%
0.01%
+200.0%
Q3 2020$4,230,000
-17.0%
306,112
-1.0%
0.00%0.0%
Q2 2020$5,099,000
+91.6%
309,191
-1.2%
0.00%
+33.3%
Q1 2020$2,661,000313,0910.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$14,540,0002.80%
Opaleye Management Inc. 281,287$10,045,0001.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$33,435,0000.66%
NEA Management Company, LLC 526,663$18,807,0000.50%
Investors Financial Group, LLC 18,200$650,0000.43%
One68 Global Capital, LLC 5,855$209,0000.42%
Wealth Advisors of Iowa, LLC 11,760$420,0000.26%
Blackstone Inc. 468,145$16,717,0000.06%
Foster Group, Inc. 7,283$221,0000.04%
Texas Yale Capital Corp. 16,000$571,0000.04%
View complete list of LUMOS PHARMA INC shareholders